Patents by Inventor Jack F. Wagner

Jack F. Wagner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Synergistic treatment method
    Patent number: 4997825
    Abstract: The concentration of endogenous growth hormone in the bloodstream of an economic mammal is increased by the simultaneous administration of an estrogen and a growth hormone releasing factor.
    Type: Grant
    Filed: October 20, 1989
    Date of Patent: March 5, 1991
    Assignee: Eli Lilly and Company
    Inventor: Jack F. Wagner
  • Growth hormone and thyroid hormone
    Patent number: 4818531
    Abstract: This invention describes a method of increasing the feed intake of pigs, chickens, or dairy cattle, which have elevated levels of growth hormone, by administering a thyroid-active substance.
    Type: Grant
    Filed: February 6, 1985
    Date of Patent: April 4, 1989
    Assignee: Eli Lilly and Company
    Inventors: David B. Anderson, Jack F. Wagner
  • Removable drug implant
    Patent number: 4191741
    Abstract: There is disclosed an implant which has an inert, biocompatible core with a coating comprising from about 5 to about 40% of estradiol in a biocompatible dimethylpolysiloxane rubber. When the implant is placed under the skin of a ruminant animal the estradiol is released at a substantially constant rate to produce a greater than normal weight gain in the animal. The implant remains intact and may be removed from the animal at the end of the desired period of drug administration.
    Type: Grant
    Filed: September 22, 1978
    Date of Patent: March 4, 1980
    Assignee: Eli Lilly and Company
    Inventors: James L. Hudson, Jack F. Wagner